Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025.
- Largest single sale: $2.3M (6,879 shares) of Amgen on Nov 12, 2025. Filing
- Last sale before this period: Feb 11, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Amgen (AMGN) | EVP, Global Commercial Ops | Nov 6, 2018 | May 11, 2026 |
| Bristol Myers Squibb (BMY) | Former EVP, Chief Commercial Officer | May 15, 2015 | Aug 3, 2018 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 7, 2026, Amgen: 615 shares withheld by the company for taxes. 1 filing: 1
- May 6, 2026, Amgen: 502 shares withheld by the company for taxes. 1 filing: 1
- May 5, 2026, Amgen: 3,640 shares granted. 1 filing: 1
- May 2, 2026, Amgen: 1,593 shares withheld by the company for taxes. 1 filing: 1
- Mar 16, 2026, Amgen: 6,691 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.